The concept
of Corrective and Preventive Action (CAPA) has doesn’t specifically appear in
the older version of Good Manufacturing Practices. CAPA seems to have become
popular in the pharmaceutical industry because of its use with medical
devices.[ISO 13495:2003 and the FDA’s 1996 Quality System Regulation (QSR) for
medical devices, include CAPA. This requirement for medical devices has been
extended to the pharmaceutical industry as an expectation by US inspectors.
There are
number of points that could trigger CAPA. For example, an investigation, a
quality audit, an inspection by national authority, or a complaint. The system
should be flexible enough to accommodate these different inputs.